Printer Friendly

TECHNICLONE INTERNATIONAL CORP. REPORTS THAT IT HAS RECEIVED A DRUG MANUFACTURING LICENSE FROM CALIFORNIA STATE FOOD AND DRUG

 TUSTIN, Calif., Nov. 18 /PRNewswire/ -- Techniclone International ("TCLN") announced that it has been issued a drug manufacturing license from the California State Food and Drug Branch of the Department of Health Services (License No. 41404).
 According to Lon H. Stone, Techniclone's president and chief executive officer, "This required license is a critical milestone for the company because it permits Techniclone's newly completed facility to produce clinical material for the intended Phase III trials of the company's LYM-1, a non-Hodgkins B-cell lymphoma drug."
 Stone also stated that, "Techniclone's manufacturing facility is designed to provide for the scaling up to produce and the commercial production of clinical material. The facility will be operated under GMP guidelines."
 Techniclone is a research and development stage company and has concentrated its efforts on developing cancer detecting and cancer fighting monoclonal antibodies.
 -0- 11/18/93
 /CONTACT: Lon H. Stone, chairman and CEO, 714-838-0500/


CO: Techniclone International Corp. ST: California IN: HEA SU:

LM-LS -- LA009 -- 5824 11/18/93 07:00 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Nov 18, 1993
Words:166
Previous Article:FREE PHONE CALLS: HOLIDAY GIFT FROM RESIDENCE INN BY MARRIOTT; $39-$79 HOLIDAY RATES ALSO ANNOUNCED
Next Article:SHOPPING FOR TOYS IS NOW EASIER AT TARGET; TOY REFERENCE GUIDE AND NEW SIGNING IN TOY AISLES MAKE SHOPPING A POSITIVE EXPERIENCE AT TARGET
Topics:

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters